Affordable Access

Publisher Website

Peak creatine kinase as a measure of effectiveness of thrombolytic therapy in acute myocardial infarction

Authors
Journal
The American Journal of Cardiology
0002-9149
Publisher
Elsevier
Publication Date
Volume
59
Issue
15
Identifiers
DOI: 10.1016/0002-9149(87)90896-4
Keywords
  • Coronary Artery Disease
Disciplines
  • Medicine

Abstract

Abstract As part of the National Heart, Lung, and Blood Institute multicenter Thrombolysis in Myocardial Infarction Trial, the time to peak plasma creatine kinase (CK) activity as a marker of reperfusion in 272 patients with validated acute myocardial infarction was analyzed. Patients were treated with either tissue-type plasminogen activator or streptokinase by intravenous administration. All patients underwent acute coronary angiography. The infarct-related artery was identified and thrombolytic therapy administered. Reperfusion at 90 minutes was documented by angiography. CK was determined before institution of therapy and every 4 hours thereafter for the first 24 hours. Patients were classified into 3 groups for comparative purposes: group 1—occlusion with no reperfusion (n = 119); group 2—occlusion with reperfusion (n = 98); and group 3—subtotal occlusion (n = 55). Early (within 4 hours after treatment) and late (more than 16 hours after treatment) peaking of CK differentiated patients with drug-induced perfusion from those without reperfusion. Although peak CK between 5 and 11 hours after drug treatment did suggest perfusion through the infarct-related artery, it did not differentiate between drug-induced and spontaneous reperfusion. Clinically, early peak CK is a useful noninvasive means of assessing coronary artery patency. However, in clinical trials assessing drug therapy, the use of peak CK may overestimate drug effectiveness by including patients with spontaneous reperfusion.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

Peak creatine kinase as a measure of effectiveness...

on The American Journal of Cardio... Jun 01, 1987

Optimised function for determining time to peak cr...

on Cardiovascular Research April 1990

Peak creatine kinase as a measure of reperfusion i...

on The American Journal of Cardio... Nov 15, 1987

Relation of temporal creatine kinase-MB release an...

on The American Journal of Cardio... Mar 01, 2000
More articles like this..